NKTR SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001193125-26-403411
NKTR filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Sep 28, 2026. An institutional holder filed an amended Schedule 13G for Nektar Therapeutics, indicating a change in passive ownership position. The stock moved +5.9% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G for Nektar Therapeutics, indicating a change in passive ownership position. The filing does not disclose a specific activist intent or material corporate event.
Key details
How NKTR stock reacted
Close before
$57.06
Sep 25, 2026
First close after
+5.85%
$60.40
5 trading days
-23.62%
$43.58
Since filing
-36.65%
$36.15
✦ Ask GOAX AI about this filing — what it means for NKTR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NKTR?
Click hereFrequently asked questions
What did NKTR file with the SEC on Sep 28, 2026?
NKTR filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Nektar Therapeutics, indicating a change in passive ownership position. The filing does not disclose a specific activist intent or material corporate event.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did NKTR stock react to this filing?
NKTR closed at $57.06 before the filing and $60.40 on Sep 28, 2026 (+5.85%). Five trading days later: $43.58 (-23.62%).
Other NKTR SEC filings
Get alerts when NKTR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days